See also this year's filing and all EDGAR filings for this company.
PDF Report 0001267813_2018_Marinus_Pharmaceuticals_INC.pdf
Logs
| warning | The stock price does not exist | industry.us_generic | {} |
| warning | Ignoring company because Expenses is zero | pre-agg | {'balance_sheet': {'company_id': '0001267813', 'EntityCommonStockSharesOutstanding': 40525013, 'Assets': 75234000, 'AssetsCurrent': 73940000, 'ComprehensiveNetIncome': -36632000, 'CostOfGoodsAndServicesSold': 0, 'Expenses': 0, 'IntangibleAssetsNetIncludingGoodwill': 0, 'Liabilities': 6909000, 'LiabilitiesAndStockholdersEquity': 75234000, 'LiabilitiesCurrent': 6909000, 'LiabilitiesNoncurrent': 0, 'NetIncome': -36726000, 'PropertyPlantAndEquipmentNet': 1294000, 'ResearchAndDevelopmentExpense': 0, 'Revenues': 0, 'SellingGeneralAndAdministrativeExpense': 0, 'remainder_Assets': 0, 'remainder_ComprehensiveNetIncome': 94000, 'remainder_Expenses': 0, 'remainder_Liabilities': 0, 'remainder_LiabilitiesAndStockholdersEquity': 68325000, 'remainder_NetIncome': -36726000, 'remainder_Revenues': 0, 'obs_EconomicCapitalRatio': nan}} |
Graph
Absolute values for 0001267813, Marinus Pharmaceuticals INC
| xvar | xval | |
|---|---|---|
| 0 | AssetsCurrent | 54,370,000 |
| 1 | IntangibleAssetsNetIncludingGoodwill | 0 |
| 2 | PropertyPlantAndEquipmentNet | 1,338,000 |
| 3 | remainder_Assets | 4,964,000 |
| 4 | LiabilitiesCurrent | 2,544,000 |
| 5 | LiabilitiesNoncurrent | 0 |
| 6 | remainder_Liabilities | 120,000 |
| 7 | CostOfGoodsAndServicesSold | 0 |
| 8 | SellingGeneralAndAdministrativeExpense | 0 |
| 9 | ResearchAndDevelopmentExpense | 0 |
| 10 | remainder_Expenses | 159,000 |
| 11 | remainder_Revenues | 0 |
| 12 | remainder_NetIncome | -18,739,000 |
| 13 | remainder_ComprehensiveNetIncome | -96,000 |
| yvar | yval | |
|---|---|---|
| 0 | Assets | 60,672,000 |
| 1 | Liabilities | 2,664,000 |
| 2 | Expenses | 159,000 |
| 3 | Revenues | 0 |
| 4 | StockholdersEquity | 58,008,000 |
| 5 | NetIncome | -18,898,000 |
| 6 | ComprehensiveNetIncome | -18,946,000 |
| 7 | BaseVar | 41,165,000 |
| 8 | EconomicCapitalRatiobeforeLimitedLiability | 3.39 |
| 9 | EconomicCapitalRatio | 3.96 |